The FDA has approved Incyte's Opzelura cream for atopic dermatitis, commonly called eczema, becoming the first and only topical JAK inhibitor registered in the US. Opzelura (ruxolitinib) – which has ...
AbbVie’s attempts to diversify beyond Humira have been boosted as its investigational drug upadacitinib has been granted Priority Review by the FDA for moderate to severe rheumatoid arthritis (RA).
Moderní žena zvládá všechno – studium nebo práci (často obojí), rodinu, vztahy i vlastní ambice. Často však na úkor sebe samé ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results